Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use (Hospitals, Physicians Clinic, Clinical Laboratories), And Segment Forecasts, 2018 - 2025

Industry Insights

The global respiratory disease testing/diagnostics market size was valued at USD 5.0 billion in 2016 and is expected to grow at a CAGR of 3.3% over the forecast period. Constantly rising incidence of respiratory diseases owing to escalating air pollution levels is the prime factor driving the growth of the market. As reported by CDC, Chronic Obstructive Pulmonary Disease (COPD) was the third main cause of death in the U.S. in 2014.

The rising rate of pollutants in the air and the release of hazardous gases causing lung diseases including COPD and other respiratory diseases around the world is driving the market. The other factors driving the overall growth include spread of infections such as tuberculosis and hospital-acquired infection where these tests are used as a preliminary detection tool.

Global respiratory disease testing market, by product, 2014 - 2025 (USD Million)

The adoption of imaging technologies, such as Computed Tomography (CT), in COPD diagnosis, is expected to drive the growth. Use of technically advanced devices, such as pulse oximeters, for effective management of COPD in outpatients is rapidly gaining recognition in the market place. Also, shift to noninvasive mechanical ventilation for COPD is expected to fuel the market growth.

Product Insights

Imaging tests captured the largest revenue share of the global respiratory disease testing market in 2016. The prime reason for the dominance of the segment is increased adoption of x-ray imaging and other imaging modalities for better visualization and a clear picture of disease condition. Furthermore, increasing demand for CT imaging is expected to drive the growth. As a result, the segment is expected to maintain its dominance throughout the forecast period.

Respiratory measurement devices, also referred to as respirometers, include spirometers, pulse oximeters, capnography, and peak flowmeters. Rising demand for pulse oximeters in this segment is higher compared to other devices. Accurate and effective diagnosis in a short time and preference for these tests by physicians are expected to trigger the growth of the segment over the forecast period.

End-use Insights

The hospital segment accounted for the largest revenue share in 2016. Installation and use of advanced respiratory diagnostic equipment, such as X-ray machines and respiratory measurement instruments including spirometers, pulse oximeters, and noninvasive ventilators in hospitals result in higher revenue generation.

Furthermore, instead of referring patients to outdoor labs, physicians prefer in-house options. In addition, hospital is the highest revenue-generating segment of the market with the largest number of patient visits. The physician’s clinic segment is anticipated to witness significant growth during the forecast period.

Global respiratory disease testing market, by end use, 2016 (%)

Regional Insights

North America captured the largest market share of more than 30% in 2016. Rising prevalence of respiratory diseases such as COPD, asthma, and other respiratory infections is the prime reason for dominance of North America. Furthermore, rising popularity of portable devices, such as advanced spirometers & noninvasive ventilators, are driving the growth.

Asia Pacific is expected to grow at the fastest rate during the forecast period. This growth can be mainly attributed to improving health care infrastructure and increasing patient awareness regarding the availability of diagnostic procedures. In addition, rising prevalence of respiratory diseases, booming medical tourism industry, and growing investments by market players in the region are some additional factors anticipated to fuel the market growth in Asia Pacific as well as Latin America.

Respiratory Disease Testing Market Share Insights

Some of the major players competing in include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V.(Respironics); ResMed Company; Fischer & Paykel, Medtronic; MGC Diagnostics Corporation and Subsidiaries; and CAREstream Medical Ltd. The players such as Becton Dickinson (Carefusion Corporation), Koninklijke Philips N.V. (Respironics), and ResMed Company have a strong market presence due to a wide product portfolio.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global respiratory disease testing market on the basis of product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Imaging test

  • Respiratory Measurement

  • Blood gas test

  • Other

• End-use Outlook (Revenue, USD Million, 2014 - 2025)

  • Hospitals

  • Physician clinics

  • Clinical laboratories

  • Others

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa